Table 2.
Shared 48 h treatments by both glucose conditions per parameter.
| MDA | ROS | Superoxide | Expression | Methylation | |||
|---|---|---|---|---|---|---|---|
| MLH1 | DNMT1 | MLH1 | LINE-1 | ||||
| Control | + | + | + | + | + | + | + |
| 25 μM H2O2 | + | + | + | + | |||
| 50 μM H2O2 | + | + | + | + | |||
| 250 μM H2O2 | + | + | + | ||||
| 500 μM H2O2 | + | + | + | ||||
| 1 mM NAC | + | + | + | ||||
| 250 μM H2O2 + 1 mM NAC | + | + | + | ||||
| 2 μM VAS2870 | + | + | + | ||||
| 250 μM H2O2 + 2 μM VAS2870 | + | + | + | ||||
| 10 μM vitamin E | + | + | + | + | + | + | + |
| 50 μM vitamin E | + | + | + | + | + | + | + |
| 25 μM H2O2 + 10 μM vitamin E | + | + | + | + | |||
| 25 μM H2O2 + 50 μM vitamin E | + | + | + | + | |||
| 50 μM H2O2 + 10 μM vitamin E | + | + | + | + | |||
| 50 μM H2O2 + 50 μM vitamin E | + | + | + | + | |||
| 250 μM H2O2 + 10 μM vitamin E | + | + | + | ||||
| 250 μM H2O2 + 50 μM vitamin E | + | + | + | ||||
| 500 μM H2O2 + 10 μM vitamin E | + | + | + | ||||
| 500 μM H2O2 + 50 μM vitamin E | + | ||||||